Clinical trials
Not yet recruiting Phase 3 Obesity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 3 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 3 |
| Novo Nordisk A/S | 3 |
| The United Bio-Technology (Hengqin) Co., Ltd. | 3 |
| Amgen | 2 |
| Pfizer | 2 |
| Carnot Laboratories | 1 |
| Eli Lilly and Company | 1 |
| FANG HE | 1 |
| Gan & Lee Pharmaceuticals. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 35 |
| Overweight | 18 |
| Sleep Apnea, Obstructive | 5 |
| Weight Loss | 5 |
| Diabetes Mellitus, Type 2 | 3 |
| Body Weight | 2 |
| Insulin Resistance | 2 |
| Agnosia | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Fatty Liver | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.